SCIENCE 37

News

 

Science 37 related announcements, media, stories, and more.

SCIENCE 37

News

 

Science 37 related announcements, media, stories, and more.

Our News
Science 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease Trial
Science 37 Nearly Doubles U.S. Enrollment for GSK…
MORRISVILLE, NC — November 21, 2024 — Science 37, a leader in enhancing patient…
https://www.science37.com/science-37-nearly-doubles-us-enrollment-gsk-phase-3-rare-disease-trial
Our News
Science 37 Earns Frost & Sullivan’s 2024 Global Company of the Year Award for Decentralized Clinical Trials
Science 37 Earns Frost & Sullivan’s 2024…
Top Honor Recognizes Science 37’s Visionary Innovation, Market-Leading Performance,…
/science-37-earns-frost-sullivans-2024-global-company-year-award-decentralized-clinical-trials
Our News
Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC
Science 37 Unveils New Corporate Headquarters in…
19,000-square-foot facility reflects the company’s recent growth and continued…
/science-37-unveils-new-corporate-headquarters-research-triangle-park-nc
Our News
Science 37 Enrolls 42% of Trial Cohort in 8 Weeks
Science 37 Enrolls 42% of Trial Cohort in 8 Weeks
Science 37 Supports Phase 3 Clinical Trial with Recruitment and Enrollment,…
/science-37-enrolls-42-trial-cohort-8-weeks
Our News
Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials
Science 37 Quickly Impacts Performance in Under-…
Nearly 20 studies have successfully leveraged Science 37's medical and operational…
/science-37-quickly-impacts-performance-under-enrolling-clinical-trials
Our News
Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial
Science 37 Surpasses Enrollment Goals,…
Science 37 Enrolls 21% of Study Participants at 11x the Speed of Traditional…
/science-37-surpasses-enrollment-goals-accelerates-phase-2-rare-disease-clinical-trial
Our News
Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance
Science 37 Metasite™ Undergoes Successful FDA…
Science 37’s Virtual Site Model for Clinical Research Impresses in First-of-its-Kind…
/science-37-metasitetm-undergoes-successful-fda-inspection-marking-major-milestone-virtual-site
Our News
Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”
Science 37 Wins 2024 MedTech Breakthrough Award…
Science 37’s Patient Recruitment Recognized in Prestigious International Annual…
/science-37-wins-2024-medtech-breakthrough-award-clinical-efficiency-innovation
Our News
Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial
Science 37 Delivers 22x Faster Enrollment than…
Partnership with Leading Biotech Company Enrolls 28% of Study Participants with 22x…
/science-37-delivers-22x-faster-enrollment-traditional-methods-phase-3-asthma-clinical-trial
Our News
Science 37 Provides Fully-Consented Patients to Sites to Supplement Enrollment
Science 37 Provides Fully Consented Patients to…
New patent-protected, central recruitment offering leverages the Science 37 Metasite…
/science-37-provides-fully-consented-patients-sites-supplement-enrollment
Our News
eMed Completes Tender Offer for All Outstanding Shares of Science 37
eMed Completes Tender Offer for All Outstanding…
MIAMI, March 12, 2024 /PRNewswire/ -- eMed, LLC ("eMed") today…
/emed-completes-tender-offer-all-outstanding-shares-science-37
News
Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment
Science 37 to be Acquired by eMed, Expanding…
Science 37 stockholders to receive $5.75 per share in cash

 

RESEARCH…
https://www.science37.com/science-37-be-acquired-emed-expanding-access-patients-and-accelerating-enrollment

© 2024  Science 37 | All Rights Reserved